Codelab Capital AS
OSE:CODE
Codelab Capital AS
Free Cash Flow
Codelab Capital AS
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Codelab Capital AS
OSE:CODE
|
Free Cash Flow
-kr69.7m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
C
|
Carasent ASA
OSE:CARA
|
Free Cash Flow
-kr32.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nordhealth AS
OSE:NORDH
|
Free Cash Flow
-€3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Omda AS
OSE:OMDA
|
Free Cash Flow
kr88.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Codelab Capital AS
Glance View
CodeLab Capital AS operates as a cloud based SaaS (Software as a Service), PaaS (Platform asa Service) and IaaS (Infrastructure as a Service) company. The company is headquartered in Oslo, Oslo and currently employs 200 full-time employees. The company went IPO on 2020-10-23. The firm is developing eHealth solutions for global healthcare and offers both Software-as-aService (SaaS), Platform-as-a-Service (PaaS) and Value-Added Services (VAS) solutions to healthcare providers and their patients. The firm's main products are the PatientSky 360 Platform, electronic health record systems and medication modules. The PatientSky 360 Platform is the core of the group's business, and is a platform that provides all the necessary building blocks for internally and partner developed modules of scalable healthcare software.
See Also
What is Codelab Capital AS's Free Cash Flow?
Free Cash Flow
-69.7m
NOK
Based on the financial report for Dec 31, 2024, Codelab Capital AS's Free Cash Flow amounts to -69.7m NOK.
What is Codelab Capital AS's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-19%
Over the last year, the Free Cash Flow growth was 28%. The average annual Free Cash Flow growth rates for Codelab Capital AS have been 22% over the past three years , -19% over the past five years .
